Find drugs by alphabetical list:
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z View All
Earnings Scorecard: Forest Labs - Zacks.com
Earnings Scorecard: Forest LabsZacks.comStrong Namenda sales, lower R&D spend and lower share count boosted earnings. Second quarter revenues increased 2.3% to $1.09 billion, with net sales ...and more��
Forest Labs Beats, Raises Outlook - Zacks.com
Forest Labs Beats, Raises OutlookZacks.comStrong Namenda sales, lower R&D spend and lower share count boosted earnings. Including one-time items, earnings came in at 61 cents per share. ...Forest Labs Q2 beats, guides upInvestor's Business DailyForest Labs 2nd qtr 2011 results beat expectations, boosted by Namenda and ...The Pharma Letter (subscription)all 11 news articles��
Looking at the Trees in Forest Laboratories - Seeking Alpha
Looking at the Trees in Forest LaboratoriesSeeking AlphaHowever, while it had a follow-on product, Lexapro (as well as the Alzheimer's drug Namenda) to restore its positive growth rate in 2006, ...and more��
Forest quarterly profit, drug sales, rise - Reuters
Proactive Investors USA & CanadaForest quarterly profit, drug sales, riseReutersN) said its fiscal second-quarter profit rose, helped by higher sales of its blood pressure medication Bystolic and Alzheimer's disease drug Namenda. ...Forest Laboratories, Inc. Reports Second Quarter Fiscal Year 2011 Earnings Per ...MarketWatch (press release)Forest Laboratories second quarter profit jumps 53% but misses sales estimatesProactive Investors USA & CanadaForest Laboratories 2Q profit grows 53 percentBusinessWeekWall Street Journal�-RTT Newsall 50 news articles��
Last updated on: Jan 24, 2007
Brand Name: | Namenda |
Active Ingredient: | memantine |
Strength(s): | 5 mg, 10 mg |
Dosage Form(s): | Tablets |
Company Name: | Forest Pharmaceuticals, Inc. |
Availability: | Prescription only |
*Date Approved by the FDA: | October 16, 2003 |
*Approval by FDA does not mean that the drug is available for consumers at this time.
This information is provided by the U.S. Food & Drug Administration.
For more information about this drug, click here. |
Namenda is for patients with moderate to severe dementia from Alzheimer?s disease.
Who should not take Namenda?
Do not take Namenda if you are allergic to Namenda or any of its ingredients.
What should I tell my health care provider?
Tell your health care provider if you:
Tell your health care provider about all the medicines you take, including prescription and non-prescription medicines, vitamins, and herbal supplements. Namenda and other medicines may affect each other, causing serious side effects. Especially tell your health care provider if you take:
What are some possible side effects of Namenda? (This is NOT a complete list of side effects reported with Namenda. Your health care provider or pharmacist can discuss with you a more complete list of side effects.)
Some common side effects with Namenda include:
Accupril
Actonel
Actos
Allegra
Altace
Atenolol
Avandia
Celebrex
Celexa
Cialis
Coreg
Cozaar
Crestor
Diovan
Effexor
Evista
Flomax
Fluoxetine
Fosamax
Glucophage
Latisse
Levitra
Levoxyl
Lexapro
Lipitor
Lisinopril
Metformin
Neurontin
Nexium
Norvasc
Paxil
Plavix
Pravachol
Premarin
Prevacid
Prilosec
Propecia
Protonix
Prozac
Seroquel
Simvastatin
Singulair
Toprol-XL
Viagra
Zetia
Zithromax
Zocor
Zoloft
Zyprexa
Zyrtec